Citadel Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $28.1M | Sell |
|
|||||
|
2022
Q2 | $34.5M | Buy |
|
|||||
|
2022
Q1 | $17.3M | Buy |
|
|||||
|
2021
Q4 | $5.62M | Sell |
|
|||||
|
2021
Q3 | $22.6M | Buy |
|
|||||
|
2021
Q2 | $3.34M | Sell |
|
|||||
|
2021
Q1 | $3M | Sell |
|
|||||
|
2020
Q4 | $10.8M | Buy |
|
|||||
|
2020
Q3 | $3.22M | Sell |
|
|||||
|
2020
Q2 | $21.8M | Buy |
|
|||||
|
2020
Q1 | $7.3M | Sell |
|
|||||
|
2019
Q4 | $15.7M | Sell |
|
|||||
|
2019
Q3 | $40M | Sell |
|
|||||
|
2019
Q2 | $56.6M | Buy |
|
|||||
|
2019
Q1 | $36M | Sell |
|
|||||
|
2018
Q4 | $34.7M | Sell |
|
|||||
|
2018
Q3 | $36.8M | Buy |
|
|||||
|
2018
Q2 | $33.6M | Buy |
|
|||||
|
2018
Q1 | $11.3M | Buy |
|
|||||
|
2017
Q4 | $7.04M | Buy |
|
|||||
|
2017
Q3 | $7.61M | Buy |
|